Literature DB >> 3992240

Activated proto-onc genes: sufficient or necessary for cancer?

P H Duesberg.   

Abstract

Proto-onc genes are normal cellular genes that are related to the transforming (onc) genes of retroviruses. Because of this relationship these genes are now widely believed to be potential cancer genes. In some tumors, proto-onc genes are mutated or expressed more than in normal cells. Under these conditions, proto-onc genes are hypothesized to be active cancer genes in one of two possible ways: The one gene-one cancer hypothesis suggests that one activated proto-onc gene is sufficient to cause cancer. The multigene-one cancer hypothesis suggests that an activated proto-onc gene is a necessary but not a sufficient cause of cancer. However, mutated or transcriptionally activated proto-onc genes are not consistently associated with the tumors in which they are occasionally found and do not transform primary cells. Further, no set of an activated proto-onc gene and a complementary cancer gene with transforming function has yet been isolated from a tumor. Thus, there is still no proof that activated proto-onc genes are sufficient or even necessary to cause cancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3992240     DOI: 10.1126/science.3992240

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  35 in total

Review 1.  Tissue culture in the study of cancer.

Authors:  S Casillo; A La Pera; L Frati
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

Review 2.  The new biomedical technology.

Authors:  C H Scoggin
Journal:  West J Med       Date:  1985-12

Review 3.  Oncogenes and cancer.

Authors:  J Weber; M McClure
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

4.  Absence of missense mutations in activated c-myc genes in avian leukosis virus-induced B-cell lymphomas.

Authors:  M Hahn; W S Hayward
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

5.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.

Authors:  E B Leof; J A Proper; A S Goustin; G D Shipley; P E DiCorleto; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Activated K-ras and N-ras oncogenes in primary renal mesenchymal tumors induced in F344 rats by methyl(methoxymethyl)nitrosamine.

Authors:  S Sukumar; A Perantoni; C Reed; J M Rice; M L Wenk
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

7.  Expression of cellular oncogenes in primary cells from human acute leukemias.

Authors:  F Mavilio; N M Sposi; M Petrini; L Bottero; M Marinucci; G De Rossi; S Amadori; F Mandelli; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 8.  Cancer models, genomic instability and somatic cellular Darwinian evolution.

Authors:  Mark P Little
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

9.  Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).

Authors:  E M Hiesiger; R L Hayes; D M Pierz; G N Budzilovich
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

Review 10.  Cancer genes: rare recombinants instead of activated oncogenes (a review).

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.